Novartis AG NVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.17% | 3.42% | 31.01% | -38.67% | -2.80% |
| Total Depreciation and Amortization | 9.17% | 0.93% | 1.19% | -6.67% | 8.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.66% | 273.25% | -59.98% | 200.63% | -75.38% |
| Change in Net Operating Assets | -1,678.95% | 98.20% | 53.81% | -314.47% | 552.76% |
| Cash from Operations | -6.44% | 60.01% | 62.37% | -65.55% | -1.40% |
| Capital Expenditure | -22.12% | 7.23% | 43.19% | -72.03% | -6.95% |
| Sale of Property, Plant, and Equipment | -- | 420.00% | 400.00% | 0.00% | 0.00% |
| Cash Acquisitions | 59.57% | 77.22% | -938.91% | -1,146.24% | 94.41% |
| Divestitures | -32.26% | 3,200.00% | 77.78% | 85.94% | -481.82% |
| Other Investing Activities | -122.48% | -119.91% | 297.56% | 6.29% | -47.06% |
| Cash from Investing | 43.77% | 73.54% | -457.79% | -144.65% | 61.66% |
| Total Debt Issued | -- | -81.23% | 127.57% | 3,697.04% | -84.12% |
| Total Debt Repaid | -782.76% | 5.43% | 95.01% | -185.29% | 3.44% |
| Issuance of Common Stock | -- | -- | -- | 100.00% | -90.00% |
| Repurchase of Common Stock | -41.62% | 36.05% | -26.69% | 35.71% | 15.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 53.67% | -- | -- | -- |
| Other Financing Activities | 102.99% | -185.90% | 162.90% | -663.64% | 110.23% |
| Cash from Financing | -21.98% | -156.44% | 112.66% | 160.34% | 46.50% |
| Foreign Exchange rate Adjustments | -116.67% | 76.62% | -313.89% | 263.64% | -105.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.69% | 116.21% | -342.58% | -35.21% | 807.32% |